Abstract: A DNA/RNA detection technology is provided. The open flow detection technique includes a substrate defining a pair of opposing microchannels, a pair of opposing electrodes in the opposing microchannels, and at least one ion exchanging nanomembrane coupled between the opposing microchannels such that the opposing microchannels are connected to each other only through the nanomembrane, wherein the nanomembrane is functionalized with a probe complementary to the macromolecule.

Abstract: Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Abstract: VTOL aircraft with a thrust-to-weight ratio smaller than 0.08, during vertical take-off/landing, obtains most vertical lift, besides traditional small vertical lift by high-temp bypass slot outlet (6) directing, under its opening, the closing of the tail of the power-off jet engine (3) by the valve (7) in tail cone, the closing and the stretching of the propelling nozzle (5), high-temp air (8) to spout out along the inclined downward direction of the wingspan, by a centrifugal impeller (13) accelerating, under the connecting of the transmission shaft (11) with a jet engine (4), and the opening of the cabin doors (15, 17) of the inlet (18) of the low-temp duct (16) and the auxiliary engine's inlet (14), low-temp air (21) to flow through the low-temp duct (21) and flow over the upper surface of the wing but not burn up it along the wingspan direction, thereby generating most vertical lift and enabling ailerons (1, 2) to control balances of the aircraft.

Abstract: VTOL aircraft with a thrust-to-weight ratio smaller than 0.1, during vertical take-off/landing, obtains another vertical lift, besides traditional vertical lift generated by low-temp bypass duct directing, under the closing of the propelling nozzle (7) of low-temp duct (6) of a turbofan engine and the opening of the inlet (14) of the low-temp bypass duct (15), the low-temp air (18) from the low-temp duct (6) to flow, in form of low-temp planar jet (20), over the upper surface of the wing along the wingspan, by high-temp bypass duct (15) directing, under the closing of the propelling nozzle (5) of high-temp duct (4) of the turbofan engine and the opening of the inlet (8) of the high-temp bypass duct (9), the high-temp air (18) from the high-temp duct (4) to flow, in form of high-temp planar jet (13), above the low-temp planar jet (20) but not burn up the wing along the wingspan and enables the ailerons (1, 2) to control the balances more efficiently.

Abstract: Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Abstract: Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Abstract: A computer-implemented method for monitoring an object-oriented application is disclosed. A transaction-representative-digraph is built based upon a real-time running of the application, and the digraph contains nodes of a plurality of replaceable classes. A key node is selected based upon invocation relationships between the nodes. A monitor program is instrumented at the selected key node.

Abstract: Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Abstract: A computer-implemented method for monitoring an object-oriented application is disclosed. A transaction-representative-digraph is built based upon a real-time running of the application, and the digraph contains nodes of a plurality of replaceable classes. A key node is selected based upon invocation relationships between the nodes. A monitor program is instrumented at the selected key node.

Abstract: An aircraft includes a jet engine with a downward deflectable propelling nozzle; an auxiliary power unit with a downward deflectable propelling nozzle; and a transformable wing. The transformable wing includes a fixed wing, hydraulic sleeve, an air intake duct including an upper wall and a lower wall, a thin wing connected to the hydraulic sleeve, a sliding wing, leading edge flaps, trailing edge flaps, an aileron, and a hinge. The transformable wing is configured, during vertical take-off/landing, to transform such that a leading end to an air intake duct in a vertical direction is formed on the fixed wing, and the air intake duct is formed internally in and along a direction of the wingspan of the fixed wing to cause air taken in by the jet engine to flow, in a common direction, over upper and lower surfaces of the thin wing, thereby generating lift for vertical take-off/landing.

Abstract: A DNA/RNA detection technology is provided. The open flow detection technique includes a substrate defining a pair of opposing microchannels, a pair of opposing electrodes in the opposing microchannels, and at least one ion exchanging nanomembrane coupled between the opposing microchannels such that the opposing microchannels are connected to each other only through the nanomembrane, wherein the nanomembrane is functionalized with a probe complementary to the macromolecule.

Abstract: A computer-implemented method for monitoring an object-oriented application is disclosed. A transaction-representative-digraph is built based upon a real-time running of the application, and the digraph contains nodes of a plurality of replaceable classes. A key node is selected based upon invocation relationships between the nodes. A monitor program is instrumented at the selected key node.

Abstract: Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Abstract: Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Abstract: An electromagnetic ultrasonic transducer and an array thereof are provided. This electromagnetic ultrasonic transducer includes a support, an elastic board disposed on the support, a magnetizer on the elastic board, and a magnet field generator for vibrating the magnetizer, wherein, the thickness of the magnetizer is of the order of microns. The thickness of the elastic board is also of the order of microns. This electromagnetic ultrasonic transducer is able to produce acoustic waves of high frequency, which are useful for ultrasonic therapy.

Abstract: Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders are described. The compositions feature peptides that activate the guanylate cyclase C (GC-C) receptor.

Abstract: An aircraft with this VTOL technology (the Invention) (6,7,8,9,10,18,19,20) can achieve VTOL even its thrust-to-weight ratio is smaller than 1. It is impossible for an aircraft with a thrust-to-weight ratio smaller than 1 to take off and land vertically with traditional technologies. The present invention, however, can achieve VTOL on these aircraft (6,7,8,9,10,18,19,20) by generating another lift force for VTOL by horizontally setting a Thin Wing (2) at the middle of the perpendicular line of the horizontal section inside the Air Intake Duct (5,6) in addition to the lift force obtained by traditional ways. This invention can be used to retrofit an existing aircraft to achieve VTOL or manufacture a VTOL aircraft with a thrust-to-weight ratio smaller than 1.

Abstract: A heat pump system operable in a cooling mode, a heating mode and a defrost mode includes a refrigerant compressor (20), a reversing valve (30), a first heat exchanger (40) and a second heat exchanger (50) disposed in a refrigerant circuit, and a primary expansion valve (45) disposed in the refrigerant circuit between said first heat exchanger (40) and said second heat exchanger (50); said reversing valve (30) is positionable in a first position for operation of said heat pump system in the cooling mode or defrost mode and is positionable in a second position for operation of said heat pump system in the heating mode; a refrigerant bypass circuit establishes a refrigerant flow path from the refrigerant circuit at a first location upstream of said primary expansion valve (45) and downstream of said first heat exchanger (40) with respect to refrigerant flow in the defrost mode to a liquid reservoir (70) disposed in the refrigerant circuit at a second location downstream of said primary expansion valve (45) with

Abstract: The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.

Abstract: A method and apparatus enhances sounding performance for a broadband wireless communication system of a multi-cell environment. A grouping part groups a plurality of sounding sequences to a plurality of sequence groups. A first determiner determines a correlation between the sequence groups. A second determiner determines a least interference relation between sectors in a cluster. An allocator allocates the sequence groups to the sectors based on the correlation between the sequence groups and the least interference relation between the sectors.